Novonesis (Novozymes) B

NZYM

Company Profile

  • Business description

    Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

  • Contact

    Krogshoejvej 36
    Bagsvaerd2880
    DNK

    T: +45 44460000

    https://www.novozymes.com

  • Sector

    Basic Materials

    Stock type

    Cyclical

  • Industry

    Specialty Chemicals

    Fiscal Year End

    31 December 2024

    Employees

    6,756

Novonesis (Novozymes) B News & Analysis

stocks

Finding bargains in global small to mid-cap stocks

Medical scopes, orthodontics, pet care and groceries have proved fertile ground for Bell Asset Management.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,633.1066.100.77%
CAC 407,185.1028.22-0.39%
DAX 4019,096.2649.91-0.26%
Dow JONES (US)43,870.35461.881.06%
FTSE 1008,207.1157.840.71%
HKSE19,229.97371.14-1.89%
NASDAQ18,972.426.280.03%
Nikkei 22538,283.85257.680.68%
NZX 50 Index13,041.90276.662.17%
S&P 5005,948.7131.600.53%
S&P/ASX 2008,393.8070.800.85%
SSE Composite Index3,267.19103.21-3.06%

Market Movers